SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 25th, 2017 • Artemis Therapeutics, Inc. • Miscellaneous chemical products • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of October 23, 2017, between Artemis Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
COMMON STOCK PURCHASE WARRANT ARTEMIS THERAPEUTICS, INC.Common Stock Purchase Warrant • October 25th, 2017 • Artemis Therapeutics, Inc. • Miscellaneous chemical products
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on October __, 2022 (the “Termination Date) but not thereafter, to subscribe for and purchase from Artemis Therapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
